NCT04475120View on ClinicalTrials.gov

Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

April 15, 2020

Primary Completion Date

July 2, 2020

Study Completion Date

July 2, 2020

Conditions
Covid19
Interventions
DRUG

liposomal lactoferrin

oral and intra-nasal formulation

DRUG

SOC therapy

oral administration

Trial Locations (1)

00133

University of Rome Tor Vergata, Rome

All Listed Sponsors
lead

University of Rome Tor Vergata

OTHER

NCT04475120 - Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients | Biotech Hunter | Biotech Hunter